Vanguard reports 10.46M Chemours shares (6.96%)
Chemours Co/The: Vanguard Portfolio Management reported beneficial ownership of 10,456,302 shares of Common Stock as of 03/31/2026.
Rhea-AI Filing Summary
Chemours Co/The: Vanguard Portfolio Management reported beneficial ownership of 10,456,302 shares of Common Stock as of 03/31/2026. This stake represents 6.96% of the class. Vanguard Portfolio Management discloses sole voting power of 130,961 shares and sole dispositive power over 10,456,302 shares.
The filing is a Schedule 13G disclosure signed on 04/29/2026 by Ashley Grim, Head of Global Fund Administration, and notes that the position includes shares held for Vanguard funds and managed accounts where Vanguard exercises dispositive power.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Schedule 13G regulatory
beneficial ownership financial
dispositive power regulatory
Investment Company Act of 1940 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Chemours (CC) does Vanguard's holding represent?
How much voting power does Vanguard report for Chemours (CC)?
Who signed the Schedule 13G for Vanguard and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.